Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Optimi Health Corp., a commercial-stage manufacturer of regulated psychedelic pharmaceutical products, announced it will participate in an H.C. investor event. The announcement provides limited new financial or operational information and is unlikely to materially affect valuation or near-term trading.